Israel 150 Logo

Israeli companies listed on US stock exchanges
Home

Evogene Ltd. (EVGN)

Evogene

Sector: Medical

Industry: Medical - Biomedical and Genetics

Exchange: Nasdaq

13 Gad Feinstein st., Park Rehovot, Rehovot 7638517, Israel

IR Contact info

Name: Rachel Pomerantz Gerber

Title: Head of Investor Relations

Email: rachel.pomerantz@evogene.com

Tel: +972-8-9311901

EVGN on Major Financial Platforms:
Rankings and awards

Evogene is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of our broadly applicable Computational Predictive Biology (CPB) platform.

The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules and genetic elements.

Utilizing the CPB platform, Evogene and its subsidiaries are now advancing product pipelines for human microbiome-based therapeutics through Biomica Ltd., medical cannabis through Canonic Ltd., ag-biologicals through Lavie Bio Ltd., ag-chemicals through AgPlenus Ltd., and ag-solutions for castor oil production through Castera Ltd.

The Executives
Sarit Firon,Chairperson of the Board
Ofer Haviv,President and CEO
Yaron Eldad,CFO
Video Presentations